Yallapu et al. (2010) demonstrated that pretreatment with curcumin sensitized cisplatin‐resistant A2780CP ovarian cancer cells, resulting in reduced required drug doses, downregulation of Bcl‐xL, Mcl‐1, and β‐catenin expression, and an increase in apoptotic markers. This evidence concerns the gene MCL1 and ovarian cancer.